Literature DB >> 17079325

Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.

Naomi Tsurutani1, Jiro Yasuda, Naoki Yamamoto, Byung-Il Choi, Motohiko Kadoki, Yoichiro Iwakura.   

Abstract

Mouse cells do not support human immunodeficiency virus type 1 (HIV-1) replication because of host range barriers at steps including virus entry, transcription, RNA splicing, polyprotein processing, assembly, and release. The exact mechanisms for the suppression, however, are not completely understood. To elucidate further the barriers against HIV-1 replication in mouse cells, we analyzed the replication of the virus in lymphocytes from human CD4/CXCR4 transgenic mice. Although primary splenocytes and thymocytes allowed the entry and reverse transcription of HIV-1, the integration efficiency of the viral DNA was greatly reduced in these cells relative to human peripheral blood mononuclear cells, suggesting an additional block(s) before or at the point of host chromosome integration of the viral DNA. Preintegration processes were further analyzed using HIV-1 pseudotyped viruses. The reverse transcription step of HIV-1 pseudotyped with the envelope of murine leukemia virus or vesicular stomatitis virus glycoprotein was efficiently supported in both human and mouse cells, but nuclear import of the preintegration complex (PIC) of HIV-1 was blocked in mouse cells. We found that green fluorescent protein (GFP)-labeled HIV-1 integrase, which is known to be important in the nuclear localization of the PIC, could not be imported into the nucleus of mouse cells, in contrast to human cells. On the other hand, GFP-Vpr localized exclusively to the nuclei of both mouse and human cells. These observations suggest that, due to the dysfunction of integrase, the nuclear localization of PIC is suppressed in mouse cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079325      PMCID: PMC1797461          DOI: 10.1128/JVI.00870-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

Review 2.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

3.  Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.

Authors:  N Tsurutani; M Kubo; Y Maeda; T Ohashi; N Yamamoto; M Kannagi; T Masuda
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.

Authors:  W Pluymers; P Cherepanov; D Schols; E De Clercq; Z Debyser
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

Review 5.  HIV-1 Tat: coping with negative elongation factors.

Authors:  M E Garber; K A Jones
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

6.  A block to human immunodeficiency virus type 1 assembly in murine cells.

Authors:  R Mariani; G Rutter; M E Harris; T J Hope; H G Kräusslich; N R Landau
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  The human T cell leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice.

Authors:  K Habu; J Nakayama-Yamada; M Asano; S Saijo; K Itagaki; R Horai; H Yamamoto; T Sekiguchi; T Nosaka; M Hatanaka; Y Iwakura
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

8.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

Authors:  M E Garber; P Wei; V N KewalRamani; T P Mayall; C H Herrmann; A P Rice; D R Littman; K A Jones
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

9.  Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1.

Authors:  Atsushi Koito; Yuichi Kameyama; Cecilia Cheng-Mayer; Shuzo Matsushita
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 10.  Early steps of retrovirus replicative cycle.

Authors:  Sébastien Nisole; Ali Saïb
Journal:  Retrovirology       Date:  2004-05-14       Impact factor: 4.602

View more
  18 in total

1.  Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.

Authors:  Sid P Kerkar; Luis Sanchez-Perez; Shicheng Yang; Zachary A Borman; Pawel Muranski; Yun Ji; Dhanalakshmi Chinnasamy; Andrew D M Kaiser; Christian S Hinrichs; Christopher A Klebanoff; Christopher D Scott; Luca Gattinoni; Richard A Morgan; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunother       Date:  2011-05       Impact factor: 4.456

2.  The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency.

Authors:  Mahdi Eskandarian Boroujeni; Mossa Gardaneh
Journal:  Mol Biotechnol       Date:  2018-03       Impact factor: 2.695

3.  Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities.

Authors:  Robert Sealy; Wendy Chaka; Sherri Surman; Scott A Brown; Peter Cresswell; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

4.  Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells.

Authors:  David M Ricks; Robert Kutner; Xian-Yang Zhang; David A Welsh; Jakob Reiser
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

5.  Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1.

Authors:  Cora L Woodward; Sarin Prakobwanakit; Sherly Mosessian; Samson A Chow
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

6.  Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors.

Authors:  Mayumi Oakland; Wendy Maury; Paul B McCray; Patrick L Sinn
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-29       Impact factor: 10.183

7.  A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria.

Authors:  Frédéric Coutant; Raul Yusef Sanchez David; Tristan Félix; Aude Boulay; Laxmee Caleechurn; Philippe Souque; Catherine Thouvenot; Catherine Bourgouin; Anne-Sophie Beignon; Pierre Charneau
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

8.  Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration.

Authors:  Hanna-Mari Tervo; Christine Goffinet; Oliver T Keppler
Journal:  Retrovirology       Date:  2008-07-08       Impact factor: 4.602

9.  Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.

Authors:  Christine Goffinet; Nico Michel; Ina Allespach; Hanna-Mari Tervo; Volker Hermann; Hans-Georg Kräusslich; Warner C Greene; Oliver T Keppler
Journal:  Retrovirology       Date:  2007-07-26       Impact factor: 4.602

10.  Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.

Authors:  Jing-xin Zhang; Gretchen E Diehl; Dan R Littman
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.